NuVasive Inventory Turnover Ratio 2006-2018 | NUVA
NuVasive inventory turnover ratio from 2006 to 2018. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
| NuVasive Inventory Turnover Ratio Historical Data | |||
|---|---|---|---|
| Date | |||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.013B | $1.030B |
| NuVasive, Inc. is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, and software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $132.164B | 26.13 |
| Medtronic (MDT) | Ireland | $123.923B | 18.53 |
| Stryker (SYK) | United States | $69.625B | 25.56 |
| Boston Scientific (BSX) | United States | $55.366B | 27.03 |
| Baxter (BAX) | United States | $39.075B | 24.08 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.222B | 16.18 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.659B | 0.00 |
| ResMed (RMD) | United States | $14.394B | 27.30 |
| Canopy Growth (CGC) | Canada | $11.042B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.100B | 51.79 |
| Aurora Cannabis (ACB) | Canada | $7.040B | 50.36 |
| Hill-Rom Holdings (HRC) | United States | $6.974B | 21.57 |
| Perrigo (PRGO) | Ireland | $6.650B | 10.09 |
| Insulet (PODD) | United States | $5.226B | 0.00 |
| ICU Medical (ICUI) | United States | $5.190B | 28.91 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.539B | 0.00 |
| Haemonetics (HAE) | United States | $4.489B | 39.82 |
| Agios Pharmaceuticals (AGIO) | United States | $3.462B | 0.00 |
| Hutchison China MediTech (HCM) | China | $3.417B | 0.00 |
| Neogen (NEOG) | United States | $3.281B | 50.39 |
| National Vision Holdings (EYE) | United States | $2.624B | 50.75 |
| Quidel (QDEL) | United States | $2.574B | 23.28 |
| Aphria (APHA) | $2.402B | 106.67 | |
| NxStage Medical (NXTM) | United States | $1.954B | 0.00 |
| AtriCure (ATRC) | United States | $1.279B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.231B | 17.70 |
| VAREX IMAGING (VREX) | United States | $1.198B | 23.45 |
| Cardiovascular Systems (CSII) | United States | $1.170B | 840.00 |
| MacroGenics (MGNX) | United States | $0.923B | 0.00 |
| Cerus (CERS) | United States | $0.878B | 0.00 |
| PetIQ (PETQ) | United States | $0.837B | 21.68 |
| Surmodics (SRDX) | United States | $0.766B | 111.39 |
| Evolus (EOLS) | United States | $0.747B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.719B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.713B | 22.07 |
| Meridian Bioscience (VIVO) | United States | $0.704B | 20.98 |
| OraSure Technologies (OSUR) | United States | $0.703B | 31.03 |
| Omeros (OMER) | United States | $0.688B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.625B | 20.05 |
| Quanterix (QTRX) | United States | $0.505B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.492B | 24.18 |
| Owens & Minor (OMI) | United States | $0.479B | 5.42 |
| TG Therapeutics (TGTX) | United States | $0.395B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.368B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.334B | 21.65 |
| BioLife Solutions (BLFS) | United States | $0.299B | 404.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.293B | 0.00 |
| Bovie Medical (APYX) | United States | $0.279B | 0.00 |
| Vapotherm (VAPO) | United States | $0.276B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.262B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.242B | 0.00 |
| Zynex (ZYXI) | United States | $0.165B | 15.97 |
| Surface Oncology (SURF) | United States | $0.150B | 0.00 |
| Fonar (FONR) | United States | $0.143B | 7.65 |
| Chembio Diagnostics (CEMI) | United States | $0.119B | 0.00 |
| Chimerix (CMRX) | United States | $0.101B | 0.00 |
| United-Guardian (UG) | United States | $0.091B | 18.98 |
| Female Health (VERU) | United States | $0.084B | 0.00 |
| CAS Medical Systems (CASM) | United States | $0.070B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.063B | 17.33 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.062B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Neurotrope (NTRP) | United States | $0.034B | 0.00 |
| Senestech (SNES) | United States | $0.021B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.013B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.013B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.011B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 13.57 |
